Pinyol and colleagues explored the mutational landscape of NASH-HCC, finding TERT promoter (56%), CTNNB1 (28%), TP53 (18%) and activin A receptor type 2A (ACVR2A; 10%) to be the most frequently mutated genes. The gene discussed is ACVR2A; the disease is metabolic dysfunction-associated steatohepatitis.